melanoma monday, national skin self-examination day, malignant melanoma, changing mole, changing birth mark

Melanoma Monday is a servicemark of the American Academy of Dermatology. is not owned, operated by, or affiliated with the American Academy of Dermatology.  This website is provided for informational purposes only.

Melanoma Monday Comming Soon! May 5, 2014

This coming Monday is Melanoma Monday – an important day to make sure that you, your family, your friends & neighbors all know about the import signs of skin cancer, and how to best reduce your risk of having a problem.

If you have any new or changing lesions on your skin, please take this opportunity to show your trusted health care professional.  Skin cancers caught early are often easily treated – so don’t delay!

Use a Sun Smart Skin Safe Bracelet on Melanoma Monday – May 6, 2013

Melanoma Monday will be May 6, 2013.

Get ready for the event with a Sun Smart Skin Safe bracelet.  These are special silicone bracelets that start out white in color, but change color to blue when exposed to ultraviolet light from the sun.  This way, you can have a fun visual reminder to protect you and your family’s skin all the time.  And the fun doesn’t end when the sun goes down.  These bracelet glows in the dark too!!

These are being sold 4 for $10, and 100% of the profits will be donated.  Donations will be made to either the Melanoma Research Foundation, Camp Discovery, or CCMAC.

Shipping is FREE for any orders in the US.  Any international orders will have to pay an additional $10 to cover extra shipping expenses.


Where Orange for Melanoma Monday – May 6, 2013

Please join us and the American Academy of Dermatology in painting the nation orange for skin cancer awareness on Monday, May 6.

It is currently estimated that one in five Americans will develop skin cancer in their lifetime.  Numbers like that make a world without skin cancer seem to be an impossible goal. But it is in  our reach. Skin cancer is highly treatable when caught early. The five-year survival rate for people whose melanoma is detected and treated before it spreads to the lymph nodes is 98 percent. Yet, sadly, one American dies from melanoma, the deadliest form of skin cancer, almost every hour.

We can make a difference by working together!

Help us spread the word and encourage others to prevent and detect skin cancer.

How you can participate  on Monday, May 6:

  • Wear orange and encourage others to join you.
  • Share a picture of you and your family, friends or co-workers wearing orange for skin cancer.

Visit for additional resources.

May 6, 2013 – Mark Your Calendars

May 6, 2013 will be Melanoma Monday.  There will be many events focused on skin health, sun safety, tanning prevention, and skin cancer screenings and resources.

United States Preventive Services Task Force Suggests Fair-Skinned Youth be Counseled to Avoid UV Rays

The United States Preventive Services Task Force (USPSTF) has prepared a draft of proposed guidelines (pdf) suggesting that physicians talk to young people with fair skin about protecting themselves from the sun’s ultraviolet (UV) rays.  This proposal is based on the best evidence based medicine available.

This decision is in line with the World Health Organization, Americanan Academy of Dermatology and American Academy of Pediatrics call for a ban on indoor tanning.  It would be a tremendous step to focus on educating our youth – as habits started young will remain with patients throughout their life and be passed on to their families.  Early intervention like this can have a huge impact over the next 50 years on decreasing skin cancer rates.

Melanoma Surveillance in the United States

The Centers for Disease Control and Prevention has published “Melanoma Surveillance in the United States ”  in the Journal of the American Academy of Dermatology. Among other findings, the report shows that “melanoma rates were higher among white females aged 50 and younger, Hispanic females aged 50 and younger, and Asian Pacific Islander females aged 40 and younger, compared to their male counterparts. This study also found that Hispanics, American Indian/Alaska Natives and Asians were diagnosed with melanoma at younger ages than whites and blacks.” CDC’s Marcus Plescia, MD, MPH, said that “new policies and prevention strategies are needed to address the leading preventable causes of melanoma.”

Dear 16 Year Old Me….

Young Women Disregard Warnings Linking Tanning To Melanoma Risk

The American Academy of Dermatology performed a study of more than 3,800 white non-Hispanic females ages 14 to 22.  They discovered 81 percent of the women “said they had tanned outdoors either frequently or occasionally in the past year.”  Tanning use increased with age, and women 18-22 years were almost twice as likely to have used indoor tanning than 14-17 year old girls.

It is disappointing to learn that 32% of young women used a tanning bed within the past year, and frightening to learn that  25% of those tanners visit a tanning bed on a weekly basis.

Britain Bans Indoor Tanning for Minors

The United Kingdom’s Sunbeds (Regulation) Act, implemented on April 8, prohibits children under 18 years of age are now banned from using ultraviolet (UV) tanning devices in Great Britain. Tanning salon staff who allow minors to tan could be liable for fines up to 20,000 pounds (about $33,000).

People who start tanning indoors before the age of 35 increase their risk of developing melanoma, the deadliest form of skin cancer, by 75 percent. UV radiation is a proven human carcinogen, and the International Agency for Research on Cancer, an affiliate of the World Health Organization, includes UV tanning devices in its list of the most dangerous cancer-causing substances.

FDA Approval Offers Hope for Melanoma Patients

It took 13 years, but melanoma patients now have access to a new treatment at long last. On March 25, the FDA approved Yervoy (also known as Ipilimumab) to treat advanced melanoma. It is the first approved therapy proven to extend the lives of late-stage melanoma patients and the Melanoma Research Foundation supported some of the early research that led to the development of this drug.

People with melanoma have urgently needed a new treatment option like this, but more work lies ahead. Advances like Yervoy demonstrate the need to intensify research efforts, particularly studies that combine therapies, to develop successful treatments.